Search

Your search keyword '"Borg, Danielle J."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Borg, Danielle J." Remove constraint Author: "Borg, Danielle J."
50 results on '"Borg, Danielle J."'

Search Results

1. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis

5. Group B Streptococcus vaginal colonisation throughout pregnancy is associated with decreased Lactobacillus crispatus and increased Lactobacillus iners abundance in the vaginal microbial community.

6. Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure

7. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.

8. Dietary supplements, guideline alignment and biochemical nutrient status in pregnancy: Findings from the Queensland Family Cohort pilot study

9. Dietary supplements, guideline alignment and biochemical nutrient status in pregnancy: Findings from the Queensland Family Cohort pilot study.

17. Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells

18. Relationship between placental elastography, maternal pre-pregnancy body mass index and gestational weight gain

19. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress

21. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes

26. Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.

28. Short Duration Alagebrium Chloride Therapy Prediabetes Does Not Inhibit Progression to Autoimmune Diabetes in an Experimental Model

29. The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)

30. Changes in placental elastography in the third trimester - analysis using a linear mixed effect model

32. Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

34. A decline in planned, but not spontaneous, preterm birth rates in a large Australian tertiary maternity centre during COVID‐19 mitigation measures.

35. Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

36. Expansion of Functional Regulatory T Cells Using Soluble RAGE Prevents Type 1 Diabetes

38. Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction

39. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes

40. Antigen-Encoding Bone Marrow Terminates Islet-Directed Memory CD8+ T-Cell Responses to Alleviate Islet Transplant Rejection

41. Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

42. Antigen-Encoding Bone Marrow Terminates Islet-Directed Memory CD8+ T-Cell Responses to Alleviate Islet Transplant Rejection

44. Modulation of pancreatic islet oxidative and ER stress with IL-22 to ameliorate metabolic syndrome in obesity

48. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes

49. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress

50. Delivery mode is a larger determinant of infant gut microbiome composition at 6 weeks than exposure to peripartum antibiotics.

Catalog

Books, media, physical & digital resources